• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中的表观遗传改变。

Epigenetic alterations in cancer.

机构信息

Department of Biochemistry, Biotechnology and Bioinformatics, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore, 641043, Tamil Nadu, India.

Redox Regulation Laboratory, Department of Zoology, Orissa University of Agriculture and Technology, Bhubaneswar-751003, India.

出版信息

Front Biosci (Landmark Ed). 2020 Mar 1;25(6):1058-1109. doi: 10.2741/4847.

DOI:10.2741/4847
PMID:32114424
Abstract

Genetic and epigenetic modifications in DNA contribute to altered gene expression in aging and cancer. In human cancers, epigenetic changes such as DNA methylation, histone modifications, micro RNAs and nucleosome remodelling all control gene expression. The link between the genetics and epigenetics in cancer is further shown by existence of aberrant metabolism and biochemical pathways in cancer or mutation in genes that are epigenetic players. Reversal of these epigenetic changes has been clearly shown to have therapeutic value in various forms of lymphoma and preleukemia and similar results are appearing for the treatment of solid tumors. In this review, we discuss the functional effects of epigenetic changes inducible by hypoxia, the epigenetic alterations in cancer and how they contribute to tumor progression and their relevance to epigenetic therapy.

摘要

DNA 的遗传和表观遗传修饰导致衰老和癌症中基因表达的改变。在人类癌症中,表观遗传变化,如 DNA 甲基化、组蛋白修饰、microRNAs 和核小体重塑,都可以控制基因表达。癌症中遗传学和表观遗传学之间的联系还表现在癌症中存在异常代谢和生化途径,或者表观遗传因子的基因突变。已经清楚地表明,逆转这些表观遗传变化在各种形式的淋巴瘤和前白血病中有治疗价值,类似的结果也出现在实体瘤的治疗中。在这篇综述中,我们讨论了缺氧诱导的表观遗传变化的功能效应、癌症中的表观遗传改变以及它们如何促进肿瘤进展,以及它们与表观遗传治疗的相关性。

相似文献

1
Epigenetic alterations in cancer.癌症中的表观遗传改变。
Front Biosci (Landmark Ed). 2020 Mar 1;25(6):1058-1109. doi: 10.2741/4847.
2
Current Insights into Oral Cancer Epigenetics.口腔癌表观遗传学的最新研究进展。
Int J Mol Sci. 2018 Feb 27;19(3):670. doi: 10.3390/ijms19030670.
3
Epigenetics in cancer: targeting chromatin modifications.癌症中的表观遗传学:靶向染色质修饰
Mol Cancer Ther. 2009 Jun;8(6):1409-20. doi: 10.1158/1535-7163.MCT-08-0860. Epub 2009 Jun 9.
4
Analytical and therapeutic profiles of DNA methylation alterations in cancer; an overview of changes in chromatin arrangement and alterations in histone surfaces.癌症中 DNA 甲基化改变的分析和治疗特征;染色质排列变化和组蛋白表面改变概述。
Horm Mol Biol Clin Investig. 2023 Feb 17;44(3):337-356. doi: 10.1515/hmbci-2022-0043. eCollection 2023 Sep 1.
5
Epigenetic modifications in cancer.癌症中的表观遗传修饰。
Clin Genet. 2012 Apr;81(4):303-11. doi: 10.1111/j.1399-0004.2011.01809.x. Epub 2011 Dec 8.
6
Interplay between different epigenetic modifications and mechanisms.不同表观遗传修饰和机制之间的相互作用。
Adv Genet. 2010;70:101-41. doi: 10.1016/B978-0-12-380866-0.60005-8.
7
A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.一种用于改变表观遗传格局的Tox21方法:评估导致体外基因表达改变和致癌转化的表观遗传毒性途径。
Int J Mol Sci. 2017 Jun 1;18(6):1179. doi: 10.3390/ijms18061179.
8
Epigenetics of Aging and Aging-Associated Diseases.衰老和与衰老相关疾病的表观遗传学。
Int J Mol Sci. 2021 Jan 2;22(1):401. doi: 10.3390/ijms22010401.
9
Epigenetics: an emerging player in gastric cancer.表观遗传学:胃癌中的一个新兴因素。
World J Gastroenterol. 2014 Jun 7;20(21):6433-47. doi: 10.3748/wjg.v20.i21.6433.
10
Diagnosis and treatment of lymphomas in the era of epigenetics.在表观遗传学时代诊断和治疗淋巴瘤。
Blood Rev. 2021 Jul;48:100782. doi: 10.1016/j.blre.2020.100782. Epub 2020 Nov 17.

引用本文的文献

1
Recent Insights into the Creation of Histone Deacetylase Inhibitors for the Treatment of Human Diseases.用于治疗人类疾病的组蛋白去乙酰化酶抑制剂创制的最新见解
Int J Mol Sci. 2025 Sep 4;26(17):8629. doi: 10.3390/ijms26178629.
2
The SPINK Protein Family in Cancer: Emerging Roles in Tumor Progression, Therapeutic Resistance, and Precision Oncology.癌症中的丝氨酸蛋白酶抑制剂Kazal型相关肽(SPINK)蛋白家族:在肿瘤进展、治疗抗性和精准肿瘤学中的新作用
Pharmaceuticals (Basel). 2025 Aug 13;18(8):1194. doi: 10.3390/ph18081194.
3
Statistical relationships across epigenomes using large-scale hierarchical clustering.
使用大规模层次聚类分析跨表观基因组的统计关系。
Bioinform Adv. 2025 Jul 23;5(1):vbaf175. doi: 10.1093/bioadv/vbaf175. eCollection 2025.
4
Targeted Degradation of Class 1 HDACs With PROTACs is Highly Effective at Inducing DLBCL Cell Death.利用PROTAC对1类组蛋白去乙酰化酶进行靶向降解在诱导弥漫性大B细胞淋巴瘤(DLBCL)细胞死亡方面非常有效。
EJHaem. 2025 Aug 12;6(4):e70127. doi: 10.1002/jha2.70127. eCollection 2025 Aug.
5
Drug resistance and tumor heterogeneity: cells and ensembles.耐药性与肿瘤异质性:细胞与细胞群体
Biophys Rev. 2025 May 31;17(3):759-779. doi: 10.1007/s12551-025-01320-y. eCollection 2025 Jun.
6
Colonic Aging and Colorectal Cancer: An Unignorable Interplay and Its Translational Implications.结肠衰老与结直肠癌:一种不容忽视的相互作用及其转化意义
Biology (Basel). 2025 Jul 3;14(7):805. doi: 10.3390/biology14070805.
7
Methylomic Changes in MTHFR Promoter Region, along with the Heterozygous C677T Polymorphism, Contribute to the Risk of Thrombotic Stroke.MTHFR启动子区域的甲基化组变化,连同杂合C677T多态性,促成血栓性中风的风险。
J Mol Neurosci. 2025 Jul 21;75(3):91. doi: 10.1007/s12031-025-02364-1.
8
Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.将表观遗传调节因子作为克服癌症治疗耐药性的一条有前景的途径。
Signal Transduct Target Ther. 2025 Jul 18;10(1):219. doi: 10.1038/s41392-025-02266-z.
9
Molecular Mechanisms of Lymphatic Metastasis in Breast Cancer: An Updated Review.乳腺癌淋巴转移的分子机制:最新综述
Cancers (Basel). 2025 Jun 25;17(13):2134. doi: 10.3390/cancers17132134.
10
Overcoming Barriers in Cancer Biology Research: Current Limitations and Solutions.克服癌症生物学研究中的障碍:当前的局限性与解决方案
Cancers (Basel). 2025 Jun 23;17(13):2102. doi: 10.3390/cancers17132102.